Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FATOKUNEUFP7IIF2010

Financiado

Cerrado

Blending biophysical and drug discovery platforms to investigate allosterism in...

Blending biophysical and drug discovery platforms to investigate allosterism in G protein coupled receptors GPCRs and find novel allosteric modulators for neurotherapeutics development "The global socio-economic and health burden of neurological and neurodegenerative diseases is enormous, impacting overall quality of life and overwhelming available resources. The situation is worrying, considering the predicted... ver más

31/07/2013

THE UNIVERSITY OF...

210K€

Presupuesto del proyecto: 210K€

Líder del proyecto

THE UNIVERSITY OF NOTTINGHAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-07-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

THE UNIVERSITY OF NOTTINGHAM

0.00€ | Lider

Proyectos interesantes

AlloGPCR

Medical Technol...

Biotechnology

247K€ Cerrado

SAF2017-87199-R

Medical Technol...

Pharmaceutical...

121K€ Cerrado

DE-ORPHAN

Medical Technol...

Data Science

1M€ Cerrado

SAF2012-40075-C02-02

Medical Technol...

Data Science

94K€ Cerrado

iGLURs - A NEW VIEW

Medical Technol...

Data Science

2M€ Cerrado

SAF2015-74627-JIN

Medical Technol...

Biotechnology

144K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

THE UNIVERSITY OF NOTTINGHAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 210K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "The global socio-economic and health burden of neurological and neurodegenerative diseases is enormous, impacting overall quality of life and overwhelming available resources. The situation is worrying, considering the predicted future explosion in the aging population. There are currently no ideal drugs to manage these debilitating conditions. This project will thus achieve two major aims: 1. Use biophysical approaches to improve fidelity of pharmacological observations of ligand-receptor interactions for determining mechanisms of action. This will allow investigations of such interactions at the single-cell level, as opposed to current investigations in cell populations, which are less accurate. 2. Use the platform in aim 1 to develop screening assays to identify allosteric modulators of three receptors of exceptional clinical significance: adenosine, metabotropic and GABAB receptors. Allosteric modulators bind to a site on the receptor different from where the endogenous ligand binds, with better selectivity and reduced incidence of side effects compared to orthosteric modulators that bind to the same place as the endogenous ligand. The inter- and multi-disciplinary project combines pharmacology, biochemistry, molecular and cell biology, medicinal and synthetic chemistry, drug discovery and biophysics. It is intersectoral, featuring collaboration with a spin-out company (CellAura). Allosteric modulators would be developed as pharmacological tools or novel drugs in an arrangement that creates opportunities for longer-term collaboration with the USA, especially Johns Hopkins University. The Fellow will bring unique expertise in drug discovery and neuroscience. He will enhance his career prospect by engaging in a novel project different in focus and approach from what he undertook previously. The project will attain ERA objectives: product and technology development, patent ownership, product commercialization and creation of spin-outs and job opportunities."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores